606 related articles for article (PubMed ID: 15946912)
1. Effect of genetic variation on therapy with angiotensin converting enzyme inhibitors or angiotensin receptor blockers in dialysis patients.
Böger CA; Götz AK; Krüger B; Hösl M; Schmitz G; Riegger GA; Krämer BK
Eur J Med Res; 2005 Apr; 10(4):161-8. PubMed ID: 15946912
[TBL] [Abstract][Full Text] [Related]
2. Genetic variation in the renin-angiotensin system modifies the beneficial effects of ACE inhibitors on the risk of diabetes mellitus among hypertensives.
Bozkurt O; Verschuren WM; van Wieren-de Wijer BM; Knol MJ; de Boer A; Grobbee DE; Geerlings MI; Heerdink ER; Klungel OH
J Hum Hypertens; 2008 Nov; 22(11):774-80. PubMed ID: 18563171
[TBL] [Abstract][Full Text] [Related]
3. Renin-angiotensin system polymorphisms and the association between use of angiotensin II receptor blockers or angiotensin-converting enzyme inhibitors and the risk of diabetes.
Bozkurt O; de Boer A; Grobbee DE; Kroon AA; Schiffers P; de Leeuw P; Klungel OH
J Renin Angiotensin Aldosterone Syst; 2009 Jun; 10(2):101-8. PubMed ID: 19502258
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of RAS inhibitors associated with ACE gene polymorphisms in type 2 diabetic nephropathy.
Seki N; Hashimoto N; Suzuki Y; Yagui K; Saito Y
Diabetes Res Clin Pract; 2006 May; 72(2):135-41. PubMed ID: 16290123
[TBL] [Abstract][Full Text] [Related]
5. Contribution of gene polymorphisms in the renin-angiotensin system to macroangiopathy in patients with diabetic nephropathy.
Wong TY; Szeto CC; Chow KM; Chan JC; Li PK
Am J Kidney Dis; 2001 Jul; 38(1):9-17. PubMed ID: 11431175
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for diabetic nephropathy: a retrospective comparison.
Robles NR; Romero B; Fernandez-Carbonero E; Sánchez-Casado E; Cubero JJ
J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):195-200. PubMed ID: 20026868
[TBL] [Abstract][Full Text] [Related]
7. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
8. Albuminuria and the renin-angiotensin system gene polymorphisms in type-2-diabetic and in normoglycemic hypertensive Chinese.
Thomas GN; Critchley JA; Tomlinson B; Lee ZS; Young RP; Cockran CS; Chan JC
Clin Nephrol; 2001 Jan; 55(1):7-15. PubMed ID: 11200871
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease.
Buraczynska M; Ksiazek P; Drop A; Zaluska W; Spasiewicz D; Ksiazek A
Nephrol Dial Transplant; 2006 Apr; 21(4):979-83. PubMed ID: 16384824
[TBL] [Abstract][Full Text] [Related]
10. Impact of renin-angiotensin system polymorphisms on renal haemodynamic responsiveness to acute angiotensin-converting enzyme inhibition in type 2 diabetes mellitus.
Volkan-Salanci B; Dagdelen S; Alikasifoglu M; Erbas T; Hayran M; Erbas B
J Renin Angiotensin Aldosterone Syst; 2009 Mar; 10(1):41-50. PubMed ID: 19286758
[TBL] [Abstract][Full Text] [Related]
11. Demonstrating the pharmacogenetic effects of angiotensin-converting enzyme inhibitors on long-term prognosis of diastolic heart failure.
Wu CK; Luo JL; Tsai CT; Huang YT; Cheng CL; Lee JK; Lin LY; Lin JW; Hwang JJ; Chiang FT
Pharmacogenomics J; 2010 Feb; 10(1):46-53. PubMed ID: 19752885
[TBL] [Abstract][Full Text] [Related]
12. Genotypic interactions of renin-angiotensin system genes with diabetes type 2 in a Tunisian population.
Mehri S; Koubaa N; Hammami S; Mahjoub S; Chaaba R; Nakbi A; Zouari B; Abid M; Ben Arab S; Baudin B; Hammami M
Life Sci; 2010 Jul; 87(1-2):49-54. PubMed ID: 20580725
[TBL] [Abstract][Full Text] [Related]
13. Renin-angiotensin system polymorphisms: a risk factor for progression to end-stage renal disease in vesicoureteral reflux patients.
Akman B; Tarhan C; Arat Z; Sezer S; Ozdemir FN
Ren Fail; 2009; 31(3):196-200. PubMed ID: 19288324
[TBL] [Abstract][Full Text] [Related]
14. The renin--angiotensin system gene polymorphisms and clinicopathological correlations in IgA nephropathy.
Ong-Ajyooth S; Ong-Ajyooth L; Limmongkon A; Tiensingh A; Parichatikanon P; Nilwarangkur S
J Med Assoc Thai; 1999 Jul; 82(7):681-9. PubMed ID: 10511770
[TBL] [Abstract][Full Text] [Related]
15. Renal function dependent association of AGTR1 polymorphism (A1166C) and electrocardiographic left-ventricular hypertrophy.
Smilde TD; Zuurman MW; Hillege HL; van Veldhuisen DJ; van Gilst WH; van der Steege G; Voors AA; Kors JA; de Jong PE; Navis G
Am J Hypertens; 2007 Oct; 20(10):1097-103. PubMed ID: 17903694
[TBL] [Abstract][Full Text] [Related]
16. Effect of HMG-CoA-reductase inhibitors on survival in type 2 diabetes patients with end stage diabetic nephropathy.
Götz AK; Böger CA; Hirschmann C; Schmitz G; Riegger GA; Krämer BK
Eur J Med Res; 2005 Apr; 10(4):155-60. PubMed ID: 15946911
[TBL] [Abstract][Full Text] [Related]
17. Renoprotective efficacy of valsartan in chronic non-diabetic proteinuric nephropathies with renin-angiotensin system gene polymorphisms.
Lee YJ; Jang HR; Kim SG; Chae DW; Do JY; Lee JE; Huh W; Kim DJ; Oh HY; Kim YG
Nephrology (Carlton); 2011 Jul; 16(5):502-10. PubMed ID: 21303424
[TBL] [Abstract][Full Text] [Related]
18. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group.
Marre M; Jeunemaitre X; Gallois Y; Rodier M; Chatellier G; Sert C; Dusselier L; Kahal Z; Chaillous L; Halimi S; Muller A; Sackmann H; Bauduceau B; Bled F; Passa P; Alhenc-Gelas F
J Clin Invest; 1997 Apr; 99(7):1585-95. PubMed ID: 9120002
[TBL] [Abstract][Full Text] [Related]
19. Survival in type 2 diabetic patients in dialysis and the number of risk alleles in polymorphisms of the renin-angiotensin system genes.
Padró-Miquel A; Alía-Ramos P; González-Alvarez MT; Navarro-Moreno MA
Clin Biochem; 2009 Jan; 42(1-2):5-11. PubMed ID: 19014923
[TBL] [Abstract][Full Text] [Related]
20. Genotypic interactions of renin-angiotensin system genes in myocardial infarction.
Araújo MA; Goulart LR; Cordeiro ER; Gatti RR; Menezes BS; Lourenço C; Silva HD
Int J Cardiol; 2005 Aug; 103(1):27-32. PubMed ID: 16061119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
